| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1561 | |
| Phytochemical name or plant extracts | Glossogyne tenuifolia extract | |
| PMID | 16029005 | |
| Literature evidence | Antioxidant activity, cytotoxicity, and DNA information of Glossogyne tenuifolia. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Ethyl acetate fraction | |
| Source of phytochemicals or plant Extracts | Glossogyne tenuifolia | |
| Geographical availability | Borneo, Caroline Is., China Southeast, East Himalaya, Fiji, Hainan, India, Kazan-retto, Lesser Sunda Is., Marianas, Myanmar, Nansei-shoto, Nepal, New Caledonia, New Guinea, New South Wales, Northern Territory, Philippines, Queensland, South Australia, Taiwan, Tanzania, Thailand, Tibet, Vanuatu, Victoria, Vietnam, West Himalaya, Western Australia | |
| Plant parts | Whole plant | |
| Other cancers | Breast cancer, Liver cancer, Lung cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 19.16 µg/mL against MDA-MB-231 7.24 µg/mL against MCF-7 | |
| Potency | Fraction 3, which did not contain luteolin, luteolin-7-glucoside, and oleanolic acid, had cytotoxicity on MDA-MB-231, MCF-7, Hep G2, Hep 3B, and A549, which implies that this fraction contained some other effective ingredients and requires further study. | |
| Cell line/ mice model | MCF-7, MDA-MB-231, Hep G2, Hep 3B | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:962665-1 | |
| Safety | NA |